| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.36 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |